Table 13.
Summary of apparent paradoxical results in multilevel and logistic modeling
| PREVIEW | IMPROVE | ADVANCE | INSIST | eNOVA | BSCORE | EXCELLENT | |
|---|---|---|---|---|---|---|---|
| Patient-related variables1 | |||||||
| Cardiovascular risk score | ✓ | ||||||
| Number of risk factors | ✓ | ||||||
| Conditions and risk factors: other | ✓ | ||||||
| Concomitant antihypertensive treatment: ACE inhibitor | ✓ | ✓ | ✓ | ||||
| Concomitant antihypertensive treatment: calcium antagonist | ✓ | ✓ | |||||
| Concomitant antihypertensive treatment: beta blocker | ✓ | ✓ | |||||
| Concomitant antihypertensive treatment: alfa blocker | ✓ | ✓ | ✓ | ||||
| Concomitant antihypertensive treatment: diuretic | ✓ | ✓ | |||||
| Concomitant antihypertensive treatment: other than alfa blocker | ✓ | ✓ | |||||
| Physician-related variables | |||||||
| Correct responses to questions related to evidence-based hypertension management | ✓ | ||||||
| Correct response to initial antihypertensive treatment if no factors present | ✓ | ||||||
| Correct response to initial antihypertensive treatment if 1 or 2 risk factors present | ✓ | ||||||
| Correct blood pressure values for hypertension diagnosis in diabetic patients | ✓ | ✓ | ✓ | ||||
| Correct blood pressure targets for diabetic patients | ✓ | ✓ | |||||
| Continuing education on hypertension in past 12 months | ✓ | ||||||
| Duration of first visit with newly diagnosed hypertensive patient | ✓ |
Abbreviation: ACE, angiotensin converting enzyme.